Bausch & Lomb CORP Form 4 insider transactions

Bausch + Lomb's EVP and CFO, Sam Eldessouky, saw 42,517 performance stock units vest, adding to his beneficial ownership.

Bausch + Lomb's President of Surgical, Luc Bonnefoy, acquired 6,146 common shares from performance stock units, reflecting met performance targets.

Bausch + Lomb's EVP of R&D and CMO, Yehia Hashad, acquired 17,715 common shares through the vesting of performance stock units.

Bausch + Lomb CEO and Chairman Brent L. Saunders disposed of 4,231 common shares to cover tax obligations related to restricted share unit vesting.

Bausch + Lomb's EVP of R&D and CMO, Yehia Hashad, reported the withholding of 2,841 common shares valued at $14.32 per share to cover tax obligations related to restricted share unit vesting.

Bausch + Lomb's President of Surgical, Luc Bonnefoy, disposed of 2,167 common shares at $14.32 each to cover tax withholding obligations related to restricted share unit vesting.

A Bausch + Lomb Corp. executive reported the disposition of 1,090 common shares on July 25, 2025, to cover tax obligations related to restricted share unit vesting.

Bausch + Lomb's EVP and CFO, Sam Eldessouky, had 3,996 common shares withheld at $14.32 per share to cover tax obligations upon the vesting of restricted share units.

Bausch + Lomb's CEO and Chairman, Brent L. Saunders, reported an amendment to his performance stock unit award, increasing the minimum number of shares eligible to vest to 900,000.

Luc Bonnefoy, President of Surgical at Bausch + Lomb Corporation, reported a routine disposition of 968 common shares valued at $12.33 per share to cover tax withholding obligations related to the vesting of restricted share units.

Bausch + Lomb Corporation's Director, Andrew C. Von Eschenbach, was granted 20,338 restricted share units as part of the company's annual non-employee director compensation plan.

Thomas W. Ross Sr., a Director at Bausch + Lomb Corporation, acquired 20,338 common shares through an annual restricted share unit grant, increasing his total beneficial ownership to 60,391 shares.

Bausch + Lomb Corporation's Director, Russel C. Robertson, was granted 20,338 restricted share units as part of the company's annual incentive plan for non-employee directors.

Bausch + Lomb Corporation (BLCO) Director and 10% Owner John Paulson has reported the acquisition of 20,338 common shares through an annual Restricted Share Unit (RSU) grant, aligning his interests with shareholders.

Bausch & Lomb Corp. Director Karen Ling was granted 20,338 restricted share units as part of her annual compensation, increasing her direct beneficial ownership to 37,676 common shares.

Bausch + Lomb Corporation's Director, Sarah B. Kavanagh, was granted 20,338 restricted share units as part of her annual compensation, increasing her total beneficial ownership to 53,699 common shares.

Bausch + Lomb Corporation's Director, Brett Icahn, was granted 20,338 common shares through an annual restricted share unit award, aligning his interests with shareholders.

Bausch + Lomb Corporation's Director, Hu Gaoxiang, was granted 20,338 restricted share units as part of the company's 2022 Omnibus Incentive Plan, increasing his total beneficial ownership to 61,147 common shares.

Nathalie D. Bernier, a Director at Bausch + Lomb Corporation, was granted 20,338 restricted share units as part of her annual compensation, vesting prior to the next annual shareholder meeting.

Bausch + Lomb's CEO and Chairman, Brent Saunders, has increased his direct beneficial ownership in the company through an open market purchase of 22,000 common shares and a grant of 22,000 matching restricted share units.

Director Andrew C. Von Eschenbach purchased 1,695 shares of Bausch & Lomb Corp at $11.755 per share on May 2, 2025, increasing his total holdings to 41,748 shares.

Director Russel C. Robertson acquires 2,210 common shares of Bausch & Lomb Corp at $11.59 per share on May 1, 2025.

Director John Paulson acquired 1,887 common shares of Bausch & Lomb Corp on May 1, 2025, at a price of $11.59 per share.

Andrew J. Stewart, an officer at Bausch & Lomb Corp, reports a transaction involving the withholding of common shares to cover tax obligations upon the vesting of restricted share units.

A. Robert D. Bailey, EVP & Chief Legal Officer of Bausch & Lomb Corp, disposed of 9,781 common shares on April 24, 2025, to cover tax withholding obligations upon vesting of restricted share units.

Luc Bonnefoy, President, Surgical at Bausch & Lomb, reports disposals of common shares to cover tax withholding obligations upon vesting of restricted share units.

Andrew J. Stewart, an officer at Bausch & Lomb, reports the acquisition of restricted stock units and stock options.

Frederick Munsch, SVP, Controller and CAO of Bausch & Lomb Corp, reports the acquisition of restricted stock units.

Luc Bonnefoy, President, Surgical at Bausch & Lomb, reports acquisition of stock options and restricted stock units.

Yehia Hashad, EVP of R&D and CMO at Bausch & Lomb, reports the acquisition of restricted stock units and stock options.